(WORX) Scworx - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US78396V1098

WORX: Software, Solutions, Data, Management, Analytics

SCWorx Corp. (NASDAQ:WORX) is a healthcare technology company focused on developing and marketing IT solutions designed to optimize operational workflows and data management within healthcare facilities. The companys product suite includes software tools for virtualized item master file management, electronic medical records, charge description master automation, contract management, and rebate management. Additionally, SCWorx offers ScanWorx, a solution for managing and integrating data from multiple sources, as well as big data analytics and modeling to support informed decision-making. Its services also extend to data normalization, interoperability, and integration of acquired businesses, addressing critical pain points in healthcare IT infrastructure.

The company primarily targets hospitals and health systems, leveraging a combination of direct sales and partnerships with distributors and resellers. SCWorx is headquartered in Tampa, Florida, and operates in the highly competitive Health Care Technology sector. Its solutions aim to address inefficiencies in healthcare data management, reducing administrative burdens and improving operational outcomes for its clients. For more information, visit their website at https://www.scworx.com.

3-Month Forecast: Based on and , SCWorx Corp. (WORX) is expected to face continued challenges in the near term. The stock has shown declining momentum, with its SMA 20, 50, and 200 all trending downward, currently at 1.10, 1.44, and 1.44, respectively. The average trading volume of 38,500 shares over the last 20 days indicates limited market interest. With a last price of $0.75 and an ATR of 0.11, the stock is expected to remain volatile but within a narrow range. From a perspective, the companys market cap of $1.72M and P/S ratio of 0.53 suggest undervaluation relative to peers, but the lack of profitability (P/E: 0.00) and RoE (None) raise concerns about its ability to generate returns. Over the next three months, WORX may struggle to gain traction, but its low valuation and niche focus could attract speculative interest from value investors.

Additional Sources for WORX Stock

WORX Stock Overview

Market Cap in USD 2m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception 2016-10-06

WORX Stock Ratings

Growth 5y -89.7%
Fundamental -56.4%
Dividend 0.0%
Rel. Strength Industry -56.8
Analysts -
Fair Price Momentum 0.37 USD
Fair Price DCF -

WORX Dividends

No Dividends Paid

WORX Growth Ratios

Growth Correlation 3m -76.4%
Growth Correlation 12m -53.9%
Growth Correlation 5y -95.4%
CAGR 5y -49.28%
CAGR/Max DD 5y -0.49
Sharpe Ratio 12m -1.53
Alpha -90.46
Beta 4.60
Volatility 146.10%
Current Volume 7.8k
Average Volume 20d 38.5k
What is the price of WORX stocks?
As of March 16, 2025, the stock is trading at USD 0.78 with a total of 7,753 shares traded.
Over the past week, the price has changed by -16.03%, over one month by -38.91%, over three months by -49.29% and over the past year by -56.41%.
Is Scworx a good stock to buy?
No, based on ValueRay Fundamental Analyses, Scworx (NASDAQ:WORX) is currently (March 2025) a stock to sell. It has a ValueRay Fundamental Rating of -56.36 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WORX as of March 2025 is 0.37. This means that WORX is currently overvalued and has a potential downside of -52.56%.
Is WORX a buy, sell or hold?
Scworx has no consensus analysts rating.
What are the forecast for WORX stock price target?
According to ValueRays Forecast Model, WORX Scworx will be worth about 0.4 in March 2026. The stock is currently trading at 0.78. This means that the stock has a potential downside of -43.59%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 0.4 -43.6%